Amy L. Burroughs is CEO at Terns Pharmaceuticals, Inc. (TERN). They have made 7 open-market trades across 2 companies since 2021, most recently 2026-03-16.
CIK 0001872564
4 open-market purchases totalling $687K since 2021, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TERN | 291,746 | $15.5M |
| DMAC | 73,288 | $558K |
| Total | $16.0M |
Shares reported on the most recent Form 4, priced at the 2026-03-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TERN | SELL · 10b5-1 | 2026-03-16 | 2026-03-17 | $46.71 | $1.4M | +15.7% | +15.2% | N/A |
| TERN | SELL | 2026-02-17 | 2026-02-18 | $39.19 | $572K | +7.3% | +23.6% | N/A |
| TERN | SELL | 2026-01-15 | 2026-01-16 | $37.07 | $2.5M | -3.7% | +11.4% | +48.3% |
| TERN | SELL | 2026-01-05 | 2026-01-06 | $38.10 | $2.7M | -3.4% | -6.7% | +39.3% |
| TERN | BUY | 2025-06-25 | 2025-06-25 | $3.87 | $180K | +6.6% | +42.4% | +76.7% |
| TERN | BUY | 2024-12-05 | 2024-12-09 | $7.15 | $221K | -11.7% | -23.4% | -50.9% |
| TERN | BUY | 2024-11-30 | 2025-02-03 | $5.11 | $3K | -6.8% | -17.1% | -24.7% |
| DMAC | BUY | 2021-08-16 | 2021-08-17 | $3.15 | $283K | +7.2% | +8.3% | +7.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.